Cian Healthcare Ltd.
| BSE: 542678 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE05BN01019 |
| BSE 00:00 | 21 Oct | 12.00 |
0 (0.00%) |
OPEN
12.00 |
HIGH
12.00 |
LOW
12.00 |
| NSE 05:30 | 01 Jan | Cian Healthcare Ltd |
| OPEN | 12.00 |
| PREVIOUS CLOSE | 12.00 |
| VOLUME | 2000 |
| 52-Week high | 27.50 |
| 52-Week low | 10.25 |
| P/E | |
| Mkt Cap.(Rs cr) | 28 |
| Buy Price | 11.40 |
| Buy Qty | 2000.00 |
| Sell Price | 12.20 |
| Sell Qty | 2000.00 |
Cian Healthcare Ltd. (CIANHEALTHCARE) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 794.55 | 9.90 | 1.26 | 13266.48 |
| Cipla | 770.45 | 25.40 | 3.41 | 12659.15 |
| Sun Pharma.Inds. | 470.65 | -3.80 | -0.80 | 12531.93 |
| Dr Reddy's Labs | 5104.00 | 123.85 | 2.49 | 11850.40 |
| Lupin | 959.70 | -3.55 | -0.37 | 11025.66 |
| Apollo Hospitals | 2110.00 | 60.45 | 2.95 | 9794.50 |
| Glenmark Pharma. | 485.90 | 8.20 | 1.72 | 6712.63 |
| Alkem Lab | 2690.60 | 94.40 | 3.64 | 6677.08 |
| Cadila Health. | 423.80 | 5.50 | 1.31 | 6347.40 |
| Torrent Pharma. | 2600.85 | -53.60 | -2.02 | 6168.44 |
| Divi's Lab. | 3165.35 | 124.35 | 4.09 | 5310.57 |
| Ipca Labs. | 2321.50 | 193.30 | 9.08 | 4337.82 |
| Piramal Enterp. | 1300.00 | -0.80 | -0.06 | 4219.19 |
| Alembic Pharma | 959.15 | 0.85 | 0.09 | 4132.55 |
| Abbott India | 15579.45 | 9.80 | 0.06 | 4093.14 |
| Glaxosmi. Pharma | 1497.65 | 6.85 | 0.46 | 3224.68 |
| Jubilant Life | 747.60 | 8.00 | 1.08 | 3139.90 |
| Sanofi India | 8389.20 | 73.55 | 0.88 | 3070.60 |
| Laurus Labs | 324.05 | 8.05 | 2.55 | 2797.34 |
| Nectar Lifesci. | 20.00 | -0.10 | -0.50 | 2362.80 |
Quick Links for Cian Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
